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The presence of erosion/malapposition of a Sirolimus eluting stent was clearly visualized
using Optical Coherence Tomography (OCT) imaging. The presence of erosion/malap-
position and the absence of neointimal hyperplasia after 10 months of sirolimus eluting
stent could constitute a potential thrombogenic substrate for late stent thrombosis.
Copyright ª 2012, Cardiological Society of India. All rights reserved.1. Introduction (140mcg/kg/h). FFRmeasured atmaximal hyperemiawas 0.93A 65 years old male, known hypertensive presented with
typical angina of one day duration. He had history of PTCA
and stenting to left circumflex artery with Cypher (Cordis, J&J)
stent 6 years ago and history of PTCA and stenting to proximal
left anterior descending artery with Cypher select plus stent
(Cordis, J&J) 10 months ago. He was on regular doses of both
aspirin and clopidogrel. His ECG and echocardiogram were
normal. Cardiac enzymes were within normal limits. In view
of the typical angina and previous history of PCI, he was taken
up for coronary angiogram. Coronary angiogram showed
patent Cypher stents in the proximal LAD and the OM.
Since patient had typical angina, and to study the stented
segments further it was decided to perform FFR and OCT.
Using standard protocol through the right radial approach
6F XB guiding catheter and intracoronary nitrates, 0.014 inch
St. Jude prime FFR wire was parked in the distal LAD. Maximal
hyperemia was achieved using intravenous adenosine2012, Cardiological Socie(Fig. 1A, B).
St. Jude 6F C7 Dragon fly OCT catheter was introduced into
LAD and OCT images were captured using standard protocol
(Fig. 1C).
Cross-sectional OCT images were analyzed at every 1 mm.
OCT images showed well demarcated areas of erosion/
malapposition in several areas of LAD stent. These are areas of
unhealed erosions or acquired malapposition which can
predispose to late stent thrombosis. These may be the
consequence of chronic inflammation and delayed healing,
resulting in tissue necrosis and erosion around the stent.
Even the struts which were well apposed did not develop
neointimal hyperplasia even after 10 months.
Then using the standard protocol and same 0.014 inch
St. Jude prime FFR wire was parked in the distal OM. Maximal
hyperemia was achieved using intravenous adenosine
(140 mcg/kg/h). FFRmeasured atmaximal hyperemiawas 0.90
in the OM (Fig. 2A, B).ty of India. All rights reserved.
Fig. 1 e AeC e Angiogram, FFR and OCT images of LAD.
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OM and OCT images were captured using standard protocol
(Fig. 2C). The OM stent was well opposed and was completely
endothelialised with well covered struts.
In contrast to LAD stent, there were no erosions or mal-
apposition in the OM stent. In view of the OCT findings of LAD
stent erosion/malapposition, his antiplatelet regimen was
changed to aspirin and prasugrel.2. Discussion
Recent IVUS studies have suggested that stent malapposition
plays an important role in patientswho develop very late stent
thrombosis after drug-eluting stent implantation. Two
mechanisms for late acquired stent malapposition (LASM)
were described: decrease of the plaque volume behind thestent (including clot lysis or plaque regression) and positive
remodeling of the vessel wall.1
Cardiovascular optical coherence tomography (OCT) is
a catheter-based invasive imaging system. Using light rather
than ultrasound, OCT produces high-resolution in vivo images
of coronary arteries and deployed stents. This imaging
modalitymay be useful not only in detecting different types of
intravascular pathology such as type of the plaque (lipid-rich,
fibrous, and calcific plaque) but also in visualizing detailed
structural changes such as ulcerated plaques, intraluminal
thrombus, tissue prolapse, stent apposition and intimal
hyperplasia in cases of in-stent restenosis.2e6
Following stent implantation, the stent is covered by
regrowth of intima, this covering of intima is difficult to assess
with IVUS as thickness of the intimal covering following
DES is less than 100 microns. OCT can assess this neointimal
covering of stent due to its high resolution capability.
Fig. 2 e AeC e Angiogram, FFR and OCT images of OM.
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found using OCT, median neointimal thickness of 53 microns
and average rate of neointimal struts covered was 89%.7
Yamamoto et al with use of OCT for SES at 2 year follow-up
found neointima of 71 microns, 5% of the struts were uncov-
ered and 10% of bifurcation lesions were uncovered.8
The mechanism by which late stent malapposition
contribute to stent thrombosis may be that it serves as a local
nidus for thrombus formation by allowing fibrin and platelet
deposition. Delayed re-endothelialization, impaired vaso-
motion, and chronic inflammation may also contribute to
stent thrombosis by allowing platelet adhesion, initiation of
the coagulation cascade, and subsequent thrombotic stent
occlusion.1
The Limus group prototype is Rapamycin (sirolimus),
a macrolide with cytostatic properties that blocks progression
from G1 to S in the cell cycle and inhibits thus the vascular
smooth muscle cell migration and proliferation.1 In patients
with sirolimus eluting stents, incomplete stent apposition can
fail to heal and even complete apposition can be associated
with no neointimal hyperplasia. Incomplete stent appositionwithout neointimal hyperplasia was significantly associated
with the presence of OCT-detected thrombus at follow-up,
and may constitute a potent substrate for late stent throm-
bosis.9 OCT may be used as guide for assessing duration of
dual antiplatelet therapy following DES implantation.3. Conclusion
The presence of erosion/malapposition and the absence of
neointimal hyperplasia after 10 months of sirolimus eluting
stent could constitute a potent thrombogenic substrate for
late stent thrombosis. The presence of erosion/malapposition
of LAD was clearly visualized using OCT-imaging and led to
changing the antiplatelet regimen in this patient.Conflicts of interest
The author has none to declare.
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